Title
Category
Credits
Event date
Cost
Expanding the Reach of Clinical Trials
  • Best Practices
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
$0.00
Although we have made some progress in ways of increasing clinical trial access to underserved communities, inequities persist. Education in this area is important because increasing access to clinical trials will have a positive impact on patient outcomes and help address current disparities in cancer treatment.
Innovative Strategies to Improve Patient Access
  • Best Practices
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
$0.00
Technology advancements in recent years have created many opportunities for improving patient access, including opportunities for self-scheduling. As practices are investing significant resources in this space it is important to understand the challenges, limitations, and impacts of these innovative approaches to solving patient access issues.
Reducing Intersectional Stigmas to Improve Outcomes in People Impacted by Cancer
  • Best Practices
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
$0.00
Intersectional stigmas in cancer care can exacerbate disparities by compounding the challenges faced by individuals who belong to multiple marginalized groups, leading to inequities in access, treatment, and outcomes. There is often a lack of consistent implementation of screening and support services that address the unique needs of marginalized patients, resulting in disparities in early detection, treatment, and follow-up care.
Preparing the Oncology Nursing Workforce: Innovative Strategies and Partnerships
  • Best Practices
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
$0.00
With the increasing complexity of cancer care and the growing population of cancer patients, the need for skilled oncology nurses is more crucial than ever. Ensuring that oncology nurses are equipped with the necessary skills and knowledge is essential for providing high-quality care and improving patient outcomes.
From Theory to Practice: Building Sustainable, High-Impact Patient Navigation Models
  • Best Practices
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
$0.00
Patient navigation is highly variable; therefore, it is important to understand the factors that contribute to program success. It is also timely given the expansion of reimbursement for these types of services, as programs are looking at the sustainability of their programs and examining ways to better build or refine existing services.
Effective and Safe Telehealth Delivery and Remote Patient Monitoring
  • Best Practices
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
$0.00
In a continuous effort to provide cost-effective, high-quality oncology care, varying degrees of telehealth delivery and remote patient monitoring are being piloted or have been implemented. Exploring this topic is a valuable exercise to help the oncology care team know what is currently being done and what is on the horizon.
New Tools for Breast Cancer Risk Assessment
  • Breast Cancer
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
$0.00
It is important for clinicians to learn about these risk assessment models, understand their limitations and benefits, and determine the best breast cancer risk reduction strategy that can be used for an individual.
Updates in the Management of Biliary Tract Cancers
  • Hepatobiliary Cancers
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
$0.00
The advent of novel targeted agents has led to a shift in the treatment paradigm of advanced biliary tract cancers. In recent years, multiple targeted agents were FDA-approved, including tumor-agnostic agents. As such, molecular profiling has become increasingly useful and can potentially help guide treatment decisions.
Treatment for Pleural and Peritoneal Mesothelioma
  • Mesothelioma
  • 0.75 AAPA Category 1 CME credit
  • 0.75 ACPE contact hours
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC contact hours
  • 0.75 Participation
$0.00
Recent phase 3 clinical trial data suggest that surgery and chemotherapy may lead to worse survival outcomes than chemotherapy alone for certain patients with pleural mesothelioma. Additionally, data on other systemic therapy regimens for the treatment of mesothelioma have been recently published.
Advances in the Treatment of Non-Metastatic Non-Small Cell Lung Cancer
  • Lung Cancers
  • 1.00 AAPA Category 1 CME credit
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 Participation
$0.00
Clinicians should be aware of all the available systemic therapy regimens as well as updated guideline recommendations on biomarker testing and treatment to ensure that patients with non-metastatic NSCLC receive the most appropriate treatments.

Pages